François Deneux
François brings over 25 years of management consulting experience with a strong focus on biotech, private equity and pharmaceutical labs.
Areas of Focus
Education
Past Experience
Francois is a Partner at Arthur D. Little in France, based in Paris, serving clients in the fields of strategy, organization, change management / transformation and due diligences.
His activity focuses first and foremost on the field of healthcare and life science (pharmaceutical labs, biotech, hospital and private equity funds).
François has developed a genuine interest in startups. He works on a regular basis with small companies (business models identification, business plan, growth strategy …) and clusters .
He is a co-author of “Incubators of the world” (Pearson 2010) which explores how new ideas can be transformed into successful businesses through the nurturing of business incubators.
François is also the co-founder of two biotech companies, one aiming at producing recombining proteins in the milk of female rabbits and the second developing a non-viral vector for gene therapy targeting kidney cancer.
François is fond of sports and especially of rugby which he played for several years.
Postal operators: The need for transformation and corresponding strategic moves
The Future of Healthcare
Francois is a Partner at Arthur D. Little in France, based in Paris, serving clients in the fields of strategy, organization, change management / transformation and due diligences.
His activity focuses first and foremost on the field of healthcare and life science (pharmaceutical labs, biotech, hospital and private equity funds).
François has developed a genuine interest in startups. He works on a regular basis with small companies (business models identification, business plan, growth strategy …) and clusters .
He is a co-author of “Incubators of the world” (Pearson 2010) which explores how new ideas can be transformed into successful businesses through the nurturing of business incubators.
François is also the co-founder of two biotech companies, one aiming at producing recombining proteins in the milk of female rabbits and the second developing a non-viral vector for gene therapy targeting kidney cancer.
François is fond of sports and especially of rugby which he played for several years.
Postal operators: The need for transformation and corresponding strategic moves
The Future of Healthcare
More About François
- ESSECMaster degree in Business
- BioProtein TechnologiesCEO
- Bossard consultingPrincipal